Open Government Canada
Notice: Prescription Drug List (PDL): Multiple Additions (2020-12-21)
Published by Health Canada | Santé Canada
About this dataset
The purpose of this Notice of Amendment is to notify about the additions of fostamatinib, givosiran, lemborexant, luspatercept, ozanimod, trientine, and voretigene neparvovec to the Prescription Drug List (PDL) for human and veterinary use.